Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  EXS

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/3-7643-7417-9_12PMID 16383005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight.

  2005cited by this paper
• Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action.

  2005cited by this paper
• Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation.

  2005cited by this paper
• High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats.

  2005cited by this paper
• Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy.

  2005cited by this paper
• Suppression of fat deposition for the life time with gene therapy.

  2005cited by this paper
• A potential decline in life expectancy in the United States in the 21st century.

  2005cited by this paper
• The epidemic of obesity.

  2004influential reference
• Obesity, metabolic syndrome, and cardiovascular disease.

  2004cited by this paper
• The pediatric obesity epidemic: causes and controversies.

  2004cited by this paper
• Brain Circuits Regulating Energy Homeostasis

  2004influential reference
• Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy.

  2004cited by this paper
• Sympathetic innervation of white adipose tissue and its regulation of fat cell number.

  2004cited by this paper
• NPY: A Novel On/Off Switch for Control of Appetite and Reproduction

  2004cited by this paper
• Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

  2004cited by this paper
• NPY--an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction.

  2004cited by this paper
• Adipose tissue as an endocrine organ.

  2004influential reference
• NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.

  2004cited by this paper
• Neuropeptide Y and Related Peptides

  2004cited by this paper
• Keeping Obesity and Metabolic Syndrome at Bay with Central Leptin and Cytokine Gene Therapy

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Neuropeptide Y

  2003cited by this paper
• Obesity and the Environment: Where Do We Go from Here?

  2003cited by this paper
• Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity.

  2003cited by this paper
• Adeno-associated Virus and AAV Vectors for Gene Delivery

  2003cited by this paper
• Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods.

  2002cited by this paper
• Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.

  2002cited by this paper
• Long-Term Suppression of Weight Gain, Adiposity, and Serum Insulin by Central Leptin Gene Therapy in Prepubertal Rats: Effects on Serum Ghrelin and Appetite-Regulating Genes

  2002cited by this paper
• Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy.

  2002cited by this paper
• Lipotoxic diseases.

  2002cited by this paper
• Ghrelin and leptin pulse discharge in fed and fasted rats.

  2002cited by this paper
• Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.

  2002cited by this paper
• Plasma Leptin Levels Are Pulsatile in Adult Rats: Effects of Gonadectomy

  2002cited by this paper
• Viral vectors as probes to decipher brain circuitry for weight control.

  2001cited by this paper
• Circumventing leptin resistance for weight control

  2001cited by this paper
• Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.

  2001cited by this paper
• Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.

  2001cited by this paper
• Selective deletion of leptin receptor in neurons leads to obesity.

  2001cited by this paper
• Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change.

  2000cited by this paper
• Interacting appetite-regulating pathways in the hypothalamic regulation of body weight.

  1999cited by this paper
• Leptin gene expression in the brain and pituitary gland.

  1999cited by this paper
• Viral vectors, tools for gene transfer in the nervous system.

  1998cited by this paper
• Efferent projection from the preoptic area for the control of non‐shivering thermogenesis in rats

  1998cited by this paper
• Diurnal rhythm in cyclic GMP/nitric oxide efflux in the medial preoptic area of male rats.

  1998cited by this paper
• Neuropeptide Y (NDY) Y1 Receptoe mRNA is Upregulated in Association with Transient Hyperphagia and Body Weight Gain: Evidence for a Hypothalamic Site for Concurrent Development of Leptin Resistance

  1998cited by this paper
• Congenital leptin deficiency is associated with severe early-onset obesity in humans

  1997cited by this paper
• Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.

  1991cited by this paper
• Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.

  1991cited by this paper

• Coexistence of Angioedema Alone with Impaired Glucose Tolerance

  2015cites this paper
• Long-term correction of type 1 and 2 diabetes by central leptin gene therapy independent of effects on appetite and energy expenditure

  2012cites this paper
• Hypothalamic leptin gene therapy prevents weight gain without long‐term detrimental effects on bone in growing and skeletally mature female rats

  2011cites this paper
• Neuroendocrine control of energy homeostasis: update on new insights.

  2010cites this paper
• Body mass influences cortical bone mass independent of leptin signaling.

  2009cites this paper
• To subjugate NPY is to improve the quality of life and live longer.

  2007cites this paper
• Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice.

  2007cites this paper
• Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.

  2007cites this paper
• Neuropeptide Y: A Conductor of the Appetite-Regulating Orchestra in the Hypothalamus

  2006cites this paper
• Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice.

  2006cites this paper
• The Melanocortin System as a Therapeutic Treatment Target for Adiposity and Adiposopathy

  2006cites this paper
• Peptide YY and Oxyntomodulin novel gene therapy treatment for obesity

  2006cites this paper